N/A
Completed N=2,896
Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes
Source: ClinicalTrials.gov NCT02416011 ↗Enrolled (actual)
2,896
Serious AEs
—
Results posted
Aug 2020
Primary outcomePrimary: Rate of Smoking Abstinence — 33; 40; 37; 42 percentage of participants
Summary
The purpose of this study is to develop and test a series of booklets designed to assist smokers of tobacco cigarettes who are also using e-cigarettes (dual users) in quitting smoking and remaining smoke-free.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rate of Smoking Abstinence |
33; 40; 37; 42; 38; 42 | — |
| SECONDARY Changes in the Use of Tobacco Products |
33; 40; 27; 32 | — |
Eligibility Criteria
Inclusion Criteria
- Study I - First Phase - No Longer Recruiting
- Greater than 1 year history of daily smoking
- 1 month or more of e-cigarette use
- Able to speak and read English
- (1) current dual users (of tobacco cigarettes and e-cigarettes) without interest in quitting smoking; (2) current dual users who have attempted, but not quit smoking; (3) current e-cigarette users who have successfully quit smoking; and (4) former dual users who have quit both products.
- Study I - Second Phase - No Longer Recruiting
- Current dual users (of tobacco cigarettes and e-cigarettes)
- Smoking at least one cigarette per day over the past year
- Using e-cigarettes at least once per week over the past month
- Not currently enrolled in a face-to-face smoking cessation program
- Able to speak and read English
- Study II - No Longer Recruiting
- Current dual users (of tobacco cigarettes and e-cigarettes)
- Smoking at least one cigarette per week over the past year
- Using e-cigarettes at least once per week over the past month
- Not currently enrolled in a face-to-face smoking cessation program
- Able to speak and read English
Data sourced from ClinicalTrials.gov (NCT02416011). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.